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Summary Vagus nerve stimulation (VNS) is a new therapeutic option for refractory
epilepsy. We report a patient with Lennox-Gastaut-Syndrome (LGS) and a severe
impairment of heart rate variability (HRV), we could demonstrate in our patient that
HRV was improved by VNS.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Vagus nerve stimulation (VNS) is a relatively new
therapeutic option for patients with refractory epi-
lepsy.4 The mode of action is complex, the afferents
of the vagus nerve first reach the nucleus tractus
solitarii which in turn has multiple connections to
many other regions of the brain. Topically differ-
entiated changes of the EEG,6,8 the cerebral perfu-
sion,5 activation patterns as studied by functional
magnetic resonance imaging are induced.
Most studies on the influence of VNS on cardiac
regulation and heart rate variability did not find
systematic effect of VNS3 but patients with asystolia
during the implantation have been described,7 and* Corresponding author. Tel.: +49 621 383 2248;
fax: +49 621 383 3818.
E-mail address: Drstkoenig@aol.com (S.A. Koenig).
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doi:10.1016/j.seizure.2007.11.004there may be a positive effect on the incidence of
SUDEP (sudden unexpected death in epilepsy) in
patients treated with VNS.1,2
We report a patient who is interesting in two
aspects: to the best of our knowledge, no patient
with epilepsy and such a severe impairment of HRV
has been reported in the past. Second, we could
demonstrate in our patient that HRV was improved
by VNS.Case report
JS was born as a preterm of 31 weeks to healthy non-
related Caucasian parents, because of premature
rupture of membranes.
Seizures began at 3 months of age and were
either tonic or myoclonic in the beginning, occur-
ring every few days at onset. The EEG showed focal. Published by Elsevier Ltd. All rights reserved.
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Figure 1 Heart frequency and the RR-intervals at rest.seizure activity located at the right frontal
brain. In the years afterwards most EEGs showed
only a diffuse slowing but no seizure activity.
Treatment was begun with phenobarbitone, car-
bamazepine was added with a limited success for
the next 6 months. Seizures reoccurred at 14
months of age, now as hemi-grand mal of the right
side, at 17 months complex partial seizures
were also seen. Hemi tonic or tonic-clonic seizures
were noted several times per week during the
night. At 20 months of age, atonic drop attacks
several times a day became prominent, and
the diagnosis of Lennox-Gastaut-Syndrome was
made.
Extensive metabolic and genetic testing did not
yield any pathological finding; repeated MRI scans
revealed a slight diffuse atrophy of the brain and
no focal pathology. The psychomotor development
was delayed, but the girl has learned to talk
normally, has impaired fine motor skills, impaired
coordination but good social skills, allowing her an
overall acceptable quality of life today at 15 years
of age.
The seizures proved to be refractory to all old and
new antiepileptic drugs, with a certain effect of
valproate on the generalized seizures and of felba-
mate on facial myoclonic seizures. Nevertheless,
the girl continued to have several seizures every
day, now prolonged atonic, shorter tonic-clonic and
occasional complex-partial seizures.
Intravenous steroids also had only a partial and
transient effect the first timewith a reduction of the
seizure frequency of about 50% and much less effect
when applied the second time.
With oxcarbazepine hyponatremia occurred but
did not recover after stopping the drug. A perma-
nent fludrocortisone substitution now keeps the
sodium level stable.
At 8 years and 6 months of age, a vagus nerve
stimulator (VNS) was implanted, with several posi-
tive effects.
A cardiologic check-up in advance including a
echocardiography and an ECG did not show any
pathologies.
Tonic-clonic seizures can be stopped very well by
additional vagus nerve stimulation when applied
immediately after the onset of seizures. This has
dramatically decreased the use of additional ben-
zodiazepines, so the patient had been able to attend
her special school again regularly, which had not
been the case for years before. Also, the wakeful-
ness, the initiative and interest improved very
much–—and deteriorated markedly before the bat-
tery was exchanged 2 years ago, returning to the
positive level with the new stimulator. Even though
prolonged atonic seizures and drop attacks continueto occur every day, the quality of life had improved
impressively with VNS.
The girl has had problems with occasional syn-
copes, sometimes with prolonged episodes of low
blood pressure below 80/40 mmHg for up to a day,
together with paleness, dizziness and a decreased
level of activity. It was not possible to clarify the
exact cause of the syncopes, assumedly the girl
showed a dysregulation of the vessels tone, any
cardiac arrhythmia could not be found. Additionally
the large amount of the used benzodiazepines
was supposed to be a supporting cause to trigger
syncopes.
Heart rate variability (HRV)
HRV refers to the beat-to-beat alterations in heart
rate. The ECG of healthy individuals exhibits peri-
odic variation in RR-intervals. This rhythmic phe-
nomenon, known as respiratory sinus arrhythmia
(RSA), fluctuates with the phase of respiration,
cardio-acceleration during inspiration, and cardio-
deceleration during expiration. RSA is predomi-
nantly mediated by parasymphathetic efferent
activity to the heart: vagal efferent traffic to the
sinus node occurs primarily in phase with expiration
and is absent or attenuated during inspiration.
Reduced HRV has thus been used as a marker of a
dysfunction in autonomic nerveous system.
The HF-band is related to the parasympathic
system, the LF-band to the sympathic system. The
ratio of the power contained in the LF and HF
components has been used as a measure of the
sympathovagal balance. Reduced HRV is a strong
predictor of mortality in myocardial infarction
and heart failure, indeed a very rigid and inflexible
HRV is related to severe dysfunctions of the ANS
(autonomic nervous system).
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Table 1 Heart frequency and the RR-intervals at rest
Value
Mean RR-interval (ms) 722
Standard deviation (ms) 16.04
Variation coefficient 2.22
Power VLF (ms2/s) 18.72
Power LF (ms2/s) 10.32
Power HF (ms2/s) 20.04
Peak frequency VLF (Hz) 0.01
Peak frequency LF (Hz) 0.05
Peak frequency HF (Hz) 0.31
RSA-quotient 1.03
HF: high frequency; LF: low frequency; VLF: very low fre-
quency; RSA: respiratory sinus arrhythmia.
Table 3 Comparison of our patient to a 12-year-old
healthy child
Patient Control
Standard deviation (ms) 20.99 75.56
Variation coefficient 2.64 8.40
RMSSD (ms) 17.1 90.23
pNN50 (%) 1 62
Power VLF (ms2/s) 11.50 447.22
Power LF (ms2/s) 13.87 503.26
Power HF (ms2/s) 20.80 960.40
LF/HF ratio 0.67 0.52
Peak frequency VLF (Hz) 0.01 0.01
Peak frequency LF (Hz) 0.05 0.11
Peak frequency HF (Hz) 0.31 0.34
RSA-quotient 1.03 1.15
HF: high frequency; LF: low frequency; VLF: very low fre-
quency; RSA: respiratory sinus arrhythmia; RMSSD: root-mean
square of differences of successive RR-intervals; pNN50: per-
cent of differences of adjacent RR-intervals >50 ms.Fig. 1 shows the heart frequency and the RR-
intervals at rest in a lying position, with the VNS
turned off. There is almost no variability of the
heart frequency, which is also quite impressing in
Table 1: the mean RR-interval was 722 ms, the
standard deviation being 16.04 ms and the variation
coefficient 2.22. The power in the very low fre-
quency (VLF)-band (0.01—0.05 Hz) was 18.72 ms2/
s, in the low frequency (LF)-band (0.05—0.15 Hz) it
was 10.32 ms2/s, in the high frequency (HF)-band
(0.15—0.5 Hz) 20.04 ms2/s.
Interestingly, the power increased impressively
as the VNS was turned on again (stimulation para-
meters: output current 3,00 mA, signal frequency
20 Hz, pulse with 500 ms, signal on 30 s, signal off
1.8 min, magnet current 3.25 mA, magnet pulse
with 500 ms). With this stimulation, the power in
the LF rose to 641.7 ms2/s, in the MF to 147.6 ms2/s,
and in the HF band to 61.81 ms2/s (Table 2). The
improved HRV and the increased power is depicted
in Fig. 2.Table 2 Heart frequency with VNS turned on
Value
Power VLF (ms2/s) 641.70
Power LF (ms2/s) 147.6
Power HF (ms2/s) 61.81
Figure 2 Heart frequency (HF) with VNS turned on.This is still clearly pathological as compared to a
healthy control child (Table 3) but the increase in
HRV and power is dramatic nevertheless as it is
usually the case in other patients.Discussion
Our patient is of interest in two aspects with view to
the ANS: the impairment of HRV is extreme, with
virtually no HRV left at all. Such findings can usually
be obtained only in critically ill patients, especially
in decerebrated individuals. In a child without any
other cause of an autonomic neuropathy who leads
an almost normal life this impairment is most unu-
sual. Second, we demonstrated a drastic increase of
HRV with VNS. VNS afferents reach many different
regions of the brain, as the Nucleus tractus solitarii
is the first target of vagus afferents.
The cause of this impairment is not quite clear. It
may be due to the severe epilepsy, to the antiepi-
leptic drugs, or HRV may not have been normal even
before the onset of seizures. Neither related to
epilepsy itself nor to antiepileptic drugs such a poor
HRV have been described before. We believe that
neither changes of respiration nor of thermoregula-
tion-related changes nor of the baroreceptor-reflex
can explain the reduction of HRV. We believe that
our patient has several pecularities (e.g. her pre-
maturity or her Lennox-Gastaut-Syndrome) that
make the girl rather unique as a patient. The auto-
nomic impairment may be considered a regulatory
defect not directly related to the other problems.
This severe impairment, however, may allow obser-
ving effects of VNS not visible in patients without
this problem.
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other patients with severly impaired ANS.References
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